Ventyx Biosciences, Inc.
VTYX
$7.94
-$1.44-15.35%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 29.03M | 29.79M | 30.63M | 31.45M | 32.18M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 116.72M | 130.40M | 136.78M | 148.45M | 166.38M |
| Operating Income | -116.72M | -130.40M | -136.78M | -148.45M | -166.38M |
| Income Before Tax | -106.61M | -119.03M | -123.99M | -135.12M | -152.52M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -106.61 | -119.03 | -123.99 | -135.12 | -152.52 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -106.61M | -119.03M | -123.99M | -135.12M | -152.52M |
| EBIT | -116.72M | -130.40M | -136.78M | -148.45M | -166.38M |
| EBITDA | -116.44M | -130.11M | -136.48M | -148.18M | -166.12M |
| EPS Basic | -1.50 | -1.68 | -1.75 | -1.99 | -2.37 |
| Normalized Basic EPS | -0.94 | -1.05 | -1.10 | -1.24 | -1.48 |
| EPS Diluted | -1.50 | -1.68 | -1.75 | -1.99 | -2.37 |
| Normalized Diluted EPS | -0.94 | -1.05 | -1.10 | -1.24 | -1.48 |
| Average Basic Shares Outstanding | 284.45M | 283.81M | 283.16M | 273.86M | 262.13M |
| Average Diluted Shares Outstanding | 284.45M | 283.81M | 283.16M | 273.86M | 262.13M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |